Physician profile
Andrew Robert Hall
NPI 1336470640
$4,727.54
in general payments reported to CMS, 2019-2025
10 companies · $1,154 in 2025
The $1,154 reported for 2025 was more than what 89% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,268 · 2020: $246 · 2021: $145 · 2022: $419 · 2023: $224 · 2024: $271 · 2025: $1,154.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $973 · Food and Beverage: $676.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $972.84 |
| Food and Beverage | $676.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,598.33 | 2019-2025 | General - Pain Management |
| Stryker Corporation | $1,086.03 | 2025 | Mild Device Kit, Optablate |
| Abbott Laboratories | $393.66 | 2020-2023 | Proclaim |
| Medtronic, INC. | $214.02 | 2024 | Synchromedii, Intellis Adaptivestim |
| Lilly USA, LLC | $181.19 | 2019-2021 | |
| Painteq LLC | $129.81 | 2023 | Painteq |
| Zimmer Biomet Holdings, INC. | $39.04 | 2022-2024 | Gel-One Cross-Linked Hyaluronate |
| Depuy Synthes Sales INC. | $32.60 | 2021 | |
| Globus Medical, INC. | $29.54 | 2025 | Senza |
| Alvogen INC | $23.32 | 2024 | Teriparatide |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Hall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.